SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,236 | -51.3% | 2,620 | -1.9% | 0.00% | – |
| Q2 2023 | $12,794 | +426366.7% | 2,671 | +352.7% | 0.00% | – |
| Q1 2023 | $3 | 0.0% | 590 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -99.9% | 590 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | +150.0% | 590 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -50.0% | 590 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | -91.8% | 590 | -90.0% | 0.00% | – |
| Q4 2021 | $49,000 | +1125.0% | 5,890 | +898.3% | 0.00% | – |
| Q3 2021 | $4,000 | -95.7% | 590 | -84.8% | 0.00% | -100.0% |
| Q2 2021 | $93,000 | +675.0% | 3,890 | +559.3% | 0.00% | – |
| Q1 2021 | $12,000 | -80.6% | 590 | -76.8% | 0.00% | – |
| Q4 2020 | $62,000 | -22.5% | 2,540 | -10.6% | 0.00% | -100.0% |
| Q3 2020 | $80,000 | +1500.0% | 2,840 | +186.9% | 0.00% | – |
| Q2 2020 | $5,000 | +25.0% | 990 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | -94.0% | 990 | -76.4% | 0.00% | -100.0% |
| Q3 2017 | $67,000 | +34.0% | 4,200 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $50,000 | – | 4,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $142,936,000 | 37.99% |
| ARK Investment Management | 629,915 | $7,099,000 | 2.05% |
| Artal Group S.A. | 600,000 | $6,762,000 | 0.15% |
| Rock Springs Capital Management LP | 220,000 | $2,479,000 | 0.14% |
| Opus Point Partners Management, LLC | 14,000 | $158,000 | 0.12% |
| HAMILTON LANE ADVISORS LLC | 14,883 | $168,000 | 0.08% |
| Virtus ETF Advisers LLC | 31,133 | $351,000 | 0.06% |
| FOX RUN MANAGEMENT, L.L.C. | 12,100 | $136,000 | 0.06% |
| Acrospire Investment Management LLC | 4,470 | $50,000 | 0.04% |
| Spark Investment Management LLC | 54,400 | $613,000 | 0.04% |